Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

For the eighth year running, the University of Oxford’s Medical School is ranked highest of all UK medical school in terms of student satisfaction.

Image courtesy of Shutterstock

The result comes from the National Student Survey, an annual online survey of all final year students in all degree courses in UK Higher Education Institutions. In the survey, 98% of Oxford medical students answered ‘agree’ or ‘definitely agree’ to the question “Overall, I am satisfied with the quality of the course.” Additionally, 87% of these students answered this question with ‘definitely agree’: by far the highest proportion in any UK medical school.

Professor David Paterson, Deputy Head & Vice Dean Medical Sciences Division (Education) commented: 'This is a very pleasing outcome and continues to demonstrate the outstanding commitment of our colleagues in providing a first class student experience in a research intensive environment.'

Dr Tim Lancaster, Director of Clinical Studies said, “This year, for the first time, the General Medical Council published pass rates for  postgraduate examinations in all medical specialties by medical school of origin. This analysis showed that Oxford graduates achieved higher levels of success than graduates of all other  UK medical schools. We are very pleased that Oxford has such positive outcomes for both these quality indicators, student satisfaction and graduate achievement.’

Links:

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.